The Texas Drug Utilization Review Board meets quarterly to develop criteria and standards impacting Texas Medicaid, including:
- Developing and submitting recommendations for the Texas Medicaid preferred drug list
- Suggesting clinical prior authorizations on outpatient prescription drugs.
- Recommending educational interventions for Medicaid providers.
- Reviewing drug utilization across the Medicaid program.
December 13, 2018
July 2018 Preferred Drug List Revised Dec. 10
December 11, 2018
Morphine Dose Limitations for Traditional Medicaid to Decrease in Jan.
November 8, 2018
October 2018 Drug Utilization Review Board Meeting Summary
November 6, 2018
Clinical Prior Authorization Assistance Chart Now Available
October 31, 2018
2019 Drug Utilization Review Board Schedule Available
October 19, 2018
July 2018 Preferred Drug List Decisions Available